|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| REVENUE | |
| OPERATING EXPENSES | |
| General and administrative | |
| Research and development | |
| Sales and marketing | |
| Total operating expenses | |
| OTHER INCOME (EXPENSES) | |
| Interest expense | |
| Other income | |
| Change in fair value of derivative liabilities | |
| Accretion of debt discount | |
| Loss on conversion of convertible notes payable | |
| Realized gain on investments | |
| Total other income (expenses) | |
| NET LOSS BEFORE TAXES | |
| NET LOSS | |
| NET LOSS PER SHARE: | |
| Net loss per share: Basic | |
| Net loss per share: Diluted | |
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING: | |
| Weighted average common shares outstanding: Basic | |
| Weighted average common shares outstanding: Diluted |
Loading...
